These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 21325085)

  • 21. On interleukin-8, neutrophil activation, and bronchiolitis obliterans syndrome in lung transplantation.
    Riise GC
    Transplantation; 2000 Jul; 70(2):265-6. PubMed ID: 10933146
    [No Abstract]   [Full Text] [Related]  

  • 22. Conversion from cyclosporine to tacrolimus stabilizes the course of lung function in lung transplant recipients with bronchiolitis obliterans syndrome.
    Borro JM; Bravo C; Solé A; Usetti P; Zurbano F; Lama R; De la Torre M; Román A; Pastor A; Laporta R; Cifrián JM; Santos F
    Transplant Proc; 2007 Sep; 39(7):2416-9. PubMed ID: 17889206
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of prophylactic use of sirolimus on bronchiolitis obliterans syndrome development in lung transplant recipients.
    Sacher VY; Fertel D; Srivastava K; Panos A; Nguyen D; Baxter T; Shafazand S; Pham SM
    Ann Thorac Surg; 2014 Jan; 97(1):268-74. PubMed ID: 24119986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New immunosuppressive regimens in lung transplantation.
    Briffa N; Morris RE
    Eur Respir J; 1997 Nov; 10(11):2630-7. PubMed ID: 9426106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibodies to human leukocyte antigens in lung transplantation.
    Hachem RR
    Clin Transpl; 2011; ():327-32. PubMed ID: 22755426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical trial of tacrolimus versus cyclosporine in lung transplantation.
    Keenan RJ; Konishi H; Kawai A; Paradis IL; Nunley DR; Iacono AT; Hardesty RL; Weyant RJ; Griffith BP
    Ann Thorac Surg; 1995 Sep; 60(3):580-4; discussion 584-5. PubMed ID: 7545889
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early administration of FTY720 prevents chronic airway as well as vascular destruction in experimental rat lung transplantation.
    Hirt SW; von Suesskind-Schwendi M; Puehler T; Schmid C; Lehle K
    Transplant Proc; 2013 Mar; 45(2):783-6. PubMed ID: 23498820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tacrolimus for treatment of bronchiolitis obliterans syndrome after unilateral and bilateral lung transplantation.
    Fieguth HG; Krueger S; Wiedenmann DE; Otterbach I; Wagner TO
    Transplant Proc; 2002 Aug; 34(5):1884. PubMed ID: 12176613
    [No Abstract]   [Full Text] [Related]  

  • 29. Preoperative introduction and maintenance immunosuppression therapy of oral-only tacrolimus, mycophenolate mofetil and steroids reduce acute rejection episodes after lung transplantation.
    Bittner HB; Barten MJ; Binner C; Lehmann S; Garbade J; Hammerschmidt S; Wirtz H; Mohr FW
    Eur J Cardiothorac Surg; 2010 Sep; 38(3):268-76. PubMed ID: 20304665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation.
    Kroshus TJ; Kshettry VR; Savik K; John R; Hertz MI; Bolman RM
    J Thorac Cardiovasc Surg; 1997 Aug; 114(2):195-202. PubMed ID: 9270635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tacrolimus-based immunosuppressive protocols in lung transplantation.
    Reichenspurner H; Kur F; Treede H; Meiser BM; Welz A; Vogelmeier C; Schwaiblmeier M; Müller C; Fürst H; Briegel J; Reichart B
    Transplant Proc; 1999; 31(1-2):171-2. PubMed ID: 10083062
    [No Abstract]   [Full Text] [Related]  

  • 32. International experience with conversion from cyclosporine to tacrolimus for acute and chronic lung allograft rejection.
    Sarahrudi K; Estenne M; Corris P; Niedermayer J; Knoop C; Glanville A; Chaparro C; Verleden G; Gerbase MW; Venuta F; Böttcher H; Aubert JD; Levvey B; Reichenspurner H; Auterith A; Klepetko W
    J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1126-32. PubMed ID: 15052212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosis, Pathophysiology and Experimental Models of Chronic Lung Allograft Rejection.
    Gauthier JM; Ruiz-Pérez D; Li W; Hachem RR; Puri V; Gelman AE; Kreisel D
    Transplantation; 2018 Sep; 102(9):1459-1466. PubMed ID: 29683998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advantage--FK 506: reduced chronic rejection for lung transplant recipients.
    Bolman RM
    Ann Thorac Surg; 1995 Sep; 60(3):495-6. PubMed ID: 7545888
    [No Abstract]   [Full Text] [Related]  

  • 35. Bronchiolitis obliterans syndrome is associated with absence of suppression of peripheral blood Th1 proinflammatory cytokines.
    Hodge G; Hodge S; Chambers D; Reynolds PN; Holmes M
    Transplantation; 2009 Jul; 88(2):211-8. PubMed ID: 19623016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tacrolimus and azathioprine versus cyclosporine and mycophenolate mofetil after lung transplantation: a retrospective cohort study.
    Celik MR; Lederer DJ; Wilt J; Eser D; Bacchetta M; D'Ovidio F; Sonett JR; Arcasoy SM
    J Heart Lung Transplant; 2009 Jul; 28(7):697-703. PubMed ID: 19560698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early lung leukocyte infiltration, HLA and adhesion molecule expression predict chronic rejection.
    Devouassoux G; Pison C; Drouet C; Pin I; Brambilla C; Brambilla E
    Transpl Immunol; 2001 Feb; 8(4):229-36. PubMed ID: 11316065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tacrolimus versus cyclosporine after lung transplantation: a prospective, open, randomized two-center trial comparing two different immunosuppressive protocols.
    Treede H; Klepetko W; Reichenspurner H; Zuckermann A; Meiser B; Birsan T; Wisser W; Reichert B;
    J Heart Lung Transplant; 2001 May; 20(5):511-7. PubMed ID: 11343977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of autoimmunity in obliterative bronchiolitis after lung transplantation.
    Weber DJ; Wilkes DS
    Am J Physiol Lung Cell Mol Physiol; 2013 Mar; 304(5):L307-11. PubMed ID: 23262227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of mycophenolate mofetil and azathioprine for prevention of bronchiolitis obliterans syndrome in de novo lung transplant recipients.
    McNeil K; Glanville AR; Wahlers T; Knoop C; Speich R; Mamelok RD; Maurer J; Ives J; Corris PA
    Transplantation; 2006 Apr; 81(7):998-1003. PubMed ID: 16612275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.